Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies Read more about Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL) Read more about A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention Read more about A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention
A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine Read more about A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine
Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution Read more about Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution
Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine Read more about Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine
Study of 4-Demethyl-4-cholesteryloxycarbonylpenclome (DM-CHOC-PEN) in Patients With Brain Tumors Read more about Study of 4-Demethyl-4-cholesteryloxycarbonylpenclome (DM-CHOC-PEN) in Patients With Brain Tumors
The BURAN Study of Buparlisib in Patients With Recurrent or Metastatic HNSCC Read more about The BURAN Study of Buparlisib in Patients With Recurrent or Metastatic HNSCC
Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in Adults Read more about Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in Adults
Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures Read more about Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures